Hellgren Karl-Johan, Bengtsson Boel
Department of Ophthalmology, Karlstad Hospital, County Council of Värmland, Karlstad, Sweden.
School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
PLoS One. 2025 Mar 25;20(3):e0320285. doi: 10.1371/journal.pone.0320285. eCollection 2025.
A better characterization of diabetic retinopathy (DR) may be helpful to monitor early disease, predict progression of DR, and to evaluate new treatment strategies. Visual function has been suggested to complement the assessment of microvascular lesions in DR but needs to be evaluated in longitudinal studies.
This prospective longitudinal cohort study investigated whether early visual field deterioration in diabetes is associated with change in DR, and whether known risk factors as diabetes duration and glycated A1c (HbA1c) affect the visual field.
People living with diabetes, 18 to 75 years of age, were consecutively recruited from the local DR screening program. Individuals with eye diseases other than DR that could affect the visual field, and those who had received previous local eye treatment for DR, could not be included. Participants who had completed a five-year follow-up were re-examined after nine and ten years from baseline. The most important outcome was deterioration in series of visual fields as determined by an experimental model tailored for people living with diabetes. Stages of DR were evaluated according to the Early Treatment Diabetic Retinopathy Study (ETDRS) scale, and glycemic control by measurement of HbA1c.
Fifty-six participants (median age 69 years at the last visit, 35 males) completed 608 out of 616 scheduled visits during ten years of follow-up. Progression and regression of DR occurred most often between no (ETDRS level 10) and minimal (ETDRS level 20) DR. The number of deteriorated test points increased annually by 11% (95% CI: 6.9-15.3) and were not associated with change in DR but with higher levels of HbA1c.
Early deterioration of visual function occurred independently of DR and was associated with worse glycemic control, suggesting that the metabolic disturbances due to diabetes induced a primary deterioration of sensitivity in the visual field.
对糖尿病视网膜病变(DR)进行更全面的特征描述可能有助于监测疾病早期情况、预测DR的进展以及评估新的治疗策略。视觉功能被认为可补充DR微血管病变的评估,但需要在纵向研究中进行评估。
这项前瞻性纵向队列研究调查了糖尿病早期视野恶化是否与DR的变化相关,以及糖尿病病程和糖化血红蛋白(HbA1c)等已知危险因素是否会影响视野。
从当地的DR筛查项目中连续招募18至75岁的糖尿病患者。患有除DR外可能影响视野的眼部疾病的个体,以及之前因DR接受过局部眼部治疗的个体均不能纳入。完成五年随访的参与者在基线后的九年和十年进行复查。最重要的结果是根据为糖尿病患者量身定制的实验模型确定的一系列视野恶化情况。根据早期糖尿病视网膜病变研究(ETDRS)量表评估DR阶段,并通过测量HbA1c评估血糖控制情况。
56名参与者(最后一次就诊时的中位年龄为69岁,男性35名)在十年随访期间完成了616次预定就诊中的608次。DR的进展和消退最常发生在无DR(ETDRS水平10)和轻度DR(ETDRS水平20)之间。恶化测试点的数量每年增加11%(95%CI:6.9-15.),且与DR的变化无关,但与较高的HbA1c水平有关。
视觉功能的早期恶化独立于DR发生,且与较差的血糖控制相关,这表明糖尿病引起的代谢紊乱导致了视野敏感性的原发性恶化。